Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
06/02/2010 | CN101249266B Nano liver target direction amphipathic nature block copolymers drug administration system and preparation |
06/01/2010 | US7728188 Methods and compositions for topical wound treatment |
06/01/2010 | US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
06/01/2010 | US7727995 Antiherpes drug combinations |
06/01/2010 | US7727994 administering adenosine receptor antagonist; side effect reduction; Parkinson's disease |
06/01/2010 | US7727993 administering adenosine receptor antagonist with dopamine antagonist;; Parkinson's disease; side effect reduction; low dosage of dopamine |
06/01/2010 | US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections |
06/01/2010 | US7727977 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes |
06/01/2010 | US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism |
06/01/2010 | US7727957 Treatment and delay of outset of Parkinson's disease |
06/01/2010 | US7727735 Detection and treatment of prostate cancer |
06/01/2010 | US7727731 Potent, selective and non toxic c-kit inhibitors |
06/01/2010 | US7727560 Treating cancer, liver, kidney, platelet and hemopoietic disorder or complication |
06/01/2010 | US7727546 Nutrient system for individualized responsive dosing regimens |
06/01/2010 | US7727536 EG-VEGF nucleic acids and polypeptides and methods of use |
06/01/2010 | US7727527 Anti-NGF antibodies for the therapeutic treatments |
06/01/2010 | US7727519 Method for treating hepatitis C virus with omega interferon |
06/01/2010 | US7727518 Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B |
06/01/2010 | CA2543640C Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action |
06/01/2010 | CA2509775C Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
06/01/2010 | CA2448737C Viral polymerase inhibitors |
06/01/2010 | CA2426625C Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
06/01/2010 | CA2420055C Fibrinogen-lowering agent |
06/01/2010 | CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors |
06/01/2010 | CA2370666C A tenascin-c isoform as a marker for neoplasias |
06/01/2010 | CA2336879C Sustained-release formulations comprising peptides, polypeptides, proteins or nucleic acids as active ingredients |
05/28/2010 | CA2645455A1 A method of medically treating an individual |
05/27/2010 | WO2010059589A1 Anticancer combination comprising docetaxel and an antisense oligonucleotide |
05/27/2010 | WO2010058824A1 Substance for regulating differentiation into mesenchymal cell, and use thereof |
05/27/2010 | WO2010057596A2 New therapy and medicament using integrin ligands for treating cancer |
05/27/2010 | WO2010057295A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain |
05/27/2010 | US20100131258 Method for identifying protein synthesis inhibitors by ribosome structure |
05/27/2010 | US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
05/27/2010 | US20100130493 Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer |
05/27/2010 | US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor |
05/27/2010 | US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
05/27/2010 | US20100129496 Nutritional formulations |
05/27/2010 | US20100129442 Oral Multi-Functional Pharmaceutical Capsule Preparations Of Proton Pump Inhibitors |
05/27/2010 | US20100129364 Combination therapy for the treatment of ocular neovascular disorders |
05/27/2010 | US20100129339 Nkt cell-stimulating agent for administration through upper respiratory tract mucous membrane |
05/27/2010 | US20100129337 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
05/27/2010 | US20100129336 Stabilized bacterial formulation |
05/27/2010 | US20100129322 Tetracycline-sensitive bifidobacteria strains |
05/27/2010 | CA2744031A1 Anticancer combination comprising docetaxel and an antisense oligonucleotide |
05/27/2010 | CA2743967A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain |
05/26/2010 | EP2189537A1 Detection and treatment of schizophrenia |
05/26/2010 | EP2189475A2 Fibroblast growth factor-like polypeptides |
05/26/2010 | EP2189162A1 Methods for the treatment of cellular proliferative disorders |
05/26/2010 | EP2189159A1 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors |
05/26/2010 | EP2187741A1 Novel forms of cddo methyl ester |
05/26/2010 | EP1685135B1 TETRAHYDRO-FURO[3,4-d]DIOXOLE COMPOUNDS AND COMPOSITIONS AND METHOD FOR INHIBITING PLATELET AGGREGATION |
05/26/2010 | EP1575379B1 Nutritional compositions |
05/26/2010 | EP1572168B1 Anti-infarction molecules |
05/26/2010 | EP1539137B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
05/26/2010 | EP1370275B1 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside |
05/26/2010 | EP1307225B1 Antagonists of cd30 or cd30l for use in treating auto-immune and chronic inflammatory conditions |
05/26/2010 | EP1294371B2 Medium chain fatty acids applicable as antimicrobial agents |
05/26/2010 | EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
05/26/2010 | EP1144642B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
05/26/2010 | EP1082875B1 Improved brush block housing for propeller deicing system |
05/26/2010 | CN1943565B Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method |
05/26/2010 | CN1935277B Preparation for the prophylaxis of restenosis |
05/26/2010 | CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
05/26/2010 | CN1893934B Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases |
05/26/2010 | CN1871010B Prophylaxis and/or treatment of portal hypertension |
05/26/2010 | CN1803189B Use of neurotoxin therapy for treatment of urologic and related disorders |
05/26/2010 | CN1803144B Pharmaceutical composition containing clofibrate compound and B family vitamin |
05/26/2010 | CN1795926B Pharamaceutical use for treating skin conditions |
05/26/2010 | CN1794976B Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
05/26/2010 | CN1781545B Method for extracting herbal medicine |
05/26/2010 | CN1753683B Ophthalmic formulation for the prevention and treatment of ocular conditions |
05/26/2010 | CN1671412B Immunostimulatory compositions and methods of stimulating an immune response |
05/26/2010 | CN1671407B Compositions and methods for treating diabetes |
05/26/2010 | CN1665933B Immunoconjugates for the treatment of tumours |
05/26/2010 | CN1665507B Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
05/26/2010 | CN1662229B Use of taurine or hypotaurine for preparing medicine for the treatment of alopecia |
05/26/2010 | CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor |
05/26/2010 | CN1635872B Proliposomal drug delivery system |
05/26/2010 | CN1553814B Remedies for arteriosclerosis |
05/26/2010 | CN1518458B Graft rejection inhibitors |
05/26/2010 | CN1468308B Anti-TNF antibodies, compositions, methods and uses |
05/26/2010 | CN1425066B Novel stra6 polypeptides |
05/26/2010 | CN101715349A therapeutic compositions and methods for treating gram-negative bacterial infections |
05/26/2010 | CN101715345A Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha |
05/26/2010 | CN101712721A T cell receptor fusions and conjugates and methods of use thereof |
05/26/2010 | CN101711869A Application of quinolones anti-bacterial medicines to curing psoriasis |
05/26/2010 | CN101711868A Gene detection assay for improving the likelihood of an effective response to a ErbB antibody cancer therapy |
05/26/2010 | CN101711862A Medicine target spot relevant to inflammatory diseases and application thereof |
05/26/2010 | CN101711755A Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis |
05/26/2010 | CN101711747A Medicine application preparation for treating hypertension |
05/26/2010 | CN101711737A Agents for intravitreal administration to treat or prevent disorders of the eye |
05/26/2010 | CN101152163B Anti-cicatrix externally used pad pasting containing hormone medicament and method for preparing the same |
05/26/2010 | CN101066458B Application of cell nucleus targeting administration system capable of reversing tumor cell resistance |
05/26/2010 | CA2645749A1 Soy kefir powder and uses thereof |
05/25/2010 | US7723505 EAAT2 promoter and uses thereof |
05/25/2010 | US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines |
05/25/2010 | US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins |
05/25/2010 | US7723496 Tumor antigen for diagnosis and treatment of cell proliferative disorders |
05/25/2010 | US7723379 Dosage form of polysaccharides, especially cocoa extracts, containing procyanidine units an additional nitric oxide modulating agent; dietary supplements; pet foods |
05/25/2010 | US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus |